Health stocks hit after Trump taps RFK Jr for top job
The news prompted a sell-off across the industry. In the US, shares in Pfizer sank more than 4% and Moderna about 7% while UK-listed firms AstraZeneca and GSK dropped more than 3%. Russ Mould, investment director at AJ Bell, said the pick had “spooked” shareholders, despite questions about how the new administration might pursue its threats.